Scholars requires JavaScript. Please enable it in your browser to view this page.
Skip to main content
Scholars
Beta
Weill Cornell Medicine
Browse
About
Sign in
Loading co-authored publications…
Feedback
Scholars
/
Jonathan Zippin, PhD, MD
/
Co-authored with Samuel Grondin
Co-authored publications
Jonathan Zippin, PhD, MD and Samuel Grondin · 4 publications
CSV
Word
Ampyrone is a direct agonist of human tyrosinase and a potential therapeutic for hypopigmentation disorders.
JCI insight
· 2026
JZ
Jonathan Zippin
SG
Samuel Grondin
ZE
Zuhal Eraslan
JB
Joseph Bonica
QC
Qiuying Chen
+1 more →
PMID:
42313478
·
PMCID:
PMC13502167
·
DOI
·
Abstract
Targeting melanosome pH is an effective method for the treatment of oculocutaneous albinism.
bioRxiv : the preprint server for biology
· 2026
JZ
Jonathan Zippin
SG
Samuel Grondin
ZE
Zuhal Eraslan
RS
Ryan Schreiner
PMID:
42244781
·
PMCID:
PMC13232348
·
DOI
·
Abstract
Ampyrone (4-Aminoantipyrine) is a Direct Agonist of Human Tyrosinase and Potential Therapeutic for Oculocutaneous Albinism and Disorders of Hypopigmentation.
bioRxiv : the preprint server for biology
· 2025
JZ
Jonathan Zippin
SG
Samuel Grondin
ZE
Zuhal Eraslan
JB
Joseph Bonica
QC
Qiuying Chen
PMID:
41279351
·
PMCID:
PMC12632964
·
DOI
·
Abstract
Two-pore channel 2 is required for soluble adenylyl cyclase-dependent regulation of melanosomal pH and melanin synthesis.
Pigment cell & melanoma research
· 2024
JZ
Jonathan Zippin
SG
Samuel Grondin
DZ
Dalee Zhou
ZE
Zuhal Eraslan
JY
Jaewon You
+2 more →
PMID:
38844435
·
PMCID:
PMC11479823
·
DOI
·
6 citations
·
Abstract